Internal Medicine, Hematology & Oncology · Portland, OR
NPI
1942203534
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
265 N Broadway St
Portland, OR, 97227
Phone (503) 280-1223
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
74,675 services
Medicare patients, 2024
242
Average age 74
Drug cost, 2024
$4.1M
1,313 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald M Segal was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 12,750 times for 21 patients. In total Gerald M Segal billed 74,675 services in 138 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-18.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 12,750 | 21 | $0.26 | $3,348 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,900 | 12 | $39.32 | $389K |
| 82784 Immunoassay | Office | 1,065 | 71 | $9.11 | $9,706 |
| 85025 Blood Count | Office | 809 | 158 | $7.61 | $6,156 |
| 80053 Clinical Chemistry | Office | 681 | 155 | $10.35 | $7,048 |
| 36415 Venipuncture Blood Collection | Office | 654 | 149 | $8.65 | $5,657 |
| 83615 Clinical Chemistry | Office | 626 | 145 | $5.92 | $3,706 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 566 | 15 | $0.09 | $51.56 |
| 83883 Clinical Chemistry | Office | 488 | 56 | $13.33 | $6,505 |
| 99213 Office E&M - Established | Office | 418 | 130 | $68.99 | $29K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 270 | 11 | $0.26 | $69.88 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 256 | 30 | $69.86 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 233 | 88 | $12.62 | $2,941 |
| 99214 Office E&M - Established | Office | 180 | 67 | $99.30 | $18K |
| 96401 Chemotherapy Administration | Office | 126 | 21 | $60.36 | $7,605 |
By year: 2022 $964K for 61,420 services; 2023 $1.4M for 75,471 services; 2024 $1.7M for 74,675 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82784 Immunoassay | 1,065 | 71 | $9.11 | $9,706 |
| 85025 Blood Count | 809 | 158 | $7.61 | $6,156 |
| 80053 Clinical Chemistry | 681 | 155 | $10.35 | $7,048 |
| 36415 Venipuncture Blood Collection | 654 | 149 | $8.65 | $5,657 |
| 83615 Clinical Chemistry | 626 | 145 | $5.92 | $3,706 |
| 83883 Clinical Chemistry | 488 | 56 | $13.33 | $6,505 |
| 83735 Clinical Chemistry | 102 | 23 | $6.57 | $670 |
| 84550 Clinical Chemistry | 63 | 17 | $4.43 | $279 |
| 83550 Clinical Chemistry | 43 | 26 | $8.57 | $369 |
| 82728 Clinical Chemistry | 43 | 26 | $13.36 | $574 |
Medicare prescription drug claims, 2024
In 2024, the drug Gerald M Segal prescribed most often to Medicare patients was Acyclovir, with 209 prescriptions and refills. In total Gerald M Segal wrote 1,313 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 209 | 372 | 41 | $3,606 |
| Eliquis Apixaban | 90 | 131 | 18 | $74K |
| Revlimid Lenalidomide | 49 | 49 | Under 11 | $1.1M |
| Pegasys Peginterferon Alfa-2a | 41 | 41 | Under 11 | $185K |
| Hydroxyurea Generic | 40 | 89 | Under 11 | $1,155 |
| Folic Acid Generic | 38 | 118 | 13 | $443 |
| Pomalyst Pomalidomide | 35 | 35 | Under 11 | $881K |
| Gabapentin Generic | 32 | 47 | Under 11 | $327 |
| Dexamethasone Generic | 29 | 43 | 15 | $1,398 |
| Allopurinol Generic | 28 | 61 | Under 11 | $327 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 66 | Under 11 | $338 |
| Lenalidomide Generic | 25 | 25 | Under 11 | $319K |
| Ondansetron Odt Ondansetron | 24 | 24 | 14 | $255 |
| Jakafi Ruxolitinib Phosphate | 21 | 21 | Under 11 | $365K |
| Imbruvica Ibrutinib | 21 | 21 | Under 11 | $312K |
Brand drugs: - claims; generic drugs: 955 claims; opioid claims: 31.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gerald M Segal were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.